Affimed NV (AFMD)
5.40
-0.09
(-1.64%)
USD |
NASDAQ |
May 07, 10:21
Affimed Shareholders Equity (Quarterly): 63.90M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 63.90M |
| September 30, 2023 | 80.89M |
| June 30, 2023 | 107.51M |
| March 31, 2023 | 136.40M |
| December 31, 2022 | 163.99M |
| September 30, 2022 | 178.00M |
| June 30, 2022 | 201.42M |
| March 31, 2022 | 131.05M |
| December 31, 2021 | 153.93M |
| September 30, 2021 | 155.26M |
| June 30, 2021 | 179.55M |
| March 31, 2021 | 197.93M |
| December 31, 2020 | 88.55M |
| September 30, 2020 | 55.20M |
| June 30, 2020 | 45.55M |
| March 31, 2020 | 34.40M |
| December 31, 2019 | 43.31M |
| September 30, 2019 | 24.33M |
| June 30, 2019 | 37.34M |
| March 31, 2019 | 47.90M |
| December 31, 2018 | 45.90M |
| Date | Value |
|---|---|
| September 30, 2018 | 41.66M |
| June 30, 2018 | 54.55M |
| March 31, 2018 | 66.90M |
| December 31, 2017 | 37.89M |
| September 30, 2017 | 39.83M |
| June 30, 2017 | 45.91M |
| March 31, 2017 | 50.86M |
| December 31, 2016 | 40.97M |
| September 30, 2016 | 48.46M |
| June 30, 2016 | 58.46M |
| March 31, 2016 | 67.73M |
| December 31, 2015 | 73.55M |
| September 30, 2015 | 60.45M |
| June 30, 2015 | 67.69M |
| March 31, 2015 | 33.19M |
| December 31, 2014 | 38.66M |
| September 30, 2014 | 47.94M |
| June 30, 2014 | -138.50M |
| March 31, 2014 | -157.98M |
| December 31, 2013 | -137.01M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
24.33M
Minimum
Sep 2019
201.42M
Maximum
Jun 2022
109.40M
Average
107.51M
Median
Jun 2023
Shareholders Equity (Quarterly) Benchmarks
| InflaRx NV | 113.39M |
| MorphoSys AG | 54.22M |
| BioNTech SE | 22.38B |
| Immatics NV | 248.81M |
| CureVac NV | 571.43M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 107.40M |
| Total Liabilities (Quarterly) | 43.50M |
| Debt to Equity Ratio | 0.2102 |
| Current Ratio | 3.250 |
| Net Debt Paydown Yield | 0.91% |